Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3,109.32 | 13.74 |
PEG Ratio (TTM) | -26.60 | -1.32 |
P/S Ratio (TTM) | 1.67 | 10.50 |
P/B Ratio (TTM) | 3.14 | 1.43 |
P/FCF Ratio (TTM) | 30.69 | 10.17 |
Price to 5YR AVG Earnings Ratio | 31.25 | 22.58 |
Price to 5YR AVG FCF Ratio | 36.70 | 42.23 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.05% | 18.03% |
ROE (TTM) | -0.10% | -0.91% |
Net Profit Margin (TTM) | -0.05% | -5.79% |
ROIC 5YR AVG | 17.93% | 10.96% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -24.98% | 101.37% | 7.99% |
Revenue | 27.02% | 2.48% | 4.19% |
Net Income | -33.33% | 103.91% | 9.77% |
Cash Flow | 41.09% | 19.57% | 10.96% |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.83 | 4.33 |
Quick Ratio (TTM) | 1.19 | 2.92 |
D/E Ratio (TTM) | 0.56 | 0.01 |
Interest Coverage (TTM) | 29.56 | 69.05 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | 2.73 | 9.27 |
LTL to 5YR AVG FCF | 6.31 | -10.55 |
Shares Outstanding Growth 5YR AVG | 0.12% | 14.39% |